微生物(英文)(mLife)(不收版面费审稿费)

微生物(英文)(mLife)(不收版面费审稿费) 知网目次万方目次维普目次

  • 国级普刊
基本信息
  • 主管单位:

    中国科学院

  • 主办单位:

    中国科学院微生物研究所

  • 国际刊号:

    2770-100X

  • 国内刊号:

    10-1839/Q

  • 学科分类:

    生物科学

  • 字数:

    4000-34000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

    010-64807055(官网电话)

  • 邮箱:

    mlife@im.ac.cnOuyanghm@im.ac.cn(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    知网目次,万方目次,维普目次

  • 级别:

    国级普刊

期刊简介

《微生物(英文)(mLife)(不收版面费审稿费)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、官网网址:http://mlife.im.ac.cn/

自动跳转至:https://www.sciengine.com/mLife/home

https://www.sciopen.com/journal/2097-1699

https://onlinelibrary.wiley.com/journal/2770100x

(微信公众号公布)

3、投稿系统:https://mc.manuscriptcentral.com/mlife

4、出刊日期:季刊,逢季末月出版。

5、官网信息:不收取出版费。

2024年4月18日星期四

mLife正式获批国内统一连续出版物号

【官方微信公众号信息】

mLife Journal 2022-04-14

2022年4月,mLife正式获批国内统一连续出版物号!

根据国家新闻出版署的批复(国新出审[2022]371号),mLife国内统一连续出版物号CN10-1839/Q,英文,季刊,大16开,公开发行,主管单位中国科学院,主办单位中国科学院微生物研究所。mLife的办刊宗旨:刊载微生物学领域研究成果,聚焦学术前沿,引领学科发展,增进国际学术交流,服务微生物学及生命科学学科建设和生物技术创新发展。

mLife于2021年1月正式启动创刊,在主管单位和主办单位的指导下,在微生物学领域海内外专家的支持下,通过编委会和编辑部的共同努力,创刊工作稳步推进。mLife获得国内统一连续出版物号,标志着mLife正式拥有了“身份证”,填补了我国微生物学领域综合性英文期刊的空白。

未来,mLife将秉承与作者、读者共同成长的理念,坚持学术至上,为微生物学科研工作者搭建一个高水平的学术交流平台。

关于mLife

作为中国微生物学领域第一本综合性高起点英文期刊,mLife及时报道国内外微生物学领域高水平科研成果和前沿进展,为微生物学科研工作者搭建一个高水平的学术交流平台。

期刊网站:http://mlife.im.ac.cn/

https://onlinelibrary.wiley.com/journal/2770100x

投稿网站:https://mc.manuscriptcentral.com/mlife

mLife@im.ac.cn

010 - 64807055

《微生物(英文)》(mLife)作者指南

【官网信息】

Author Guidelines

1. Aims and Scope

mLife is an open access microbiology journal sponsored by the Institute of Microbiology of the Chinese Academy of Sciences and the Chinese Society for Microbiology. The journal publishes novel and high-impact discoveries in a wide spectrum of microbiological disciplines including, but not limited to, the following:

Biodiversity, Ecology & Evolution

Biochemistry, Genetics & Molecular Biology

Metabolism & Physiology

Pathogenesis & Immunity

Public Health Microbiology & Infection Control

Inter-microbe & Microbe-Host Interactions

Microbiomes

Environmental Microbiology

Geomicrobiology

Bioinformatics & Data Sciences

Synthetic Biology & Biotechnology

Methods & Instrumentation

2. Submission and Peer Review Process

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/mlife.

For help with submissions, please contact: mlife@im.ac.cn.

This journal does not charge submission fees.

Article Preparation Support

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Preprint Policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers. Authors are requested to update any pre-publication versions with a link to the final published article, and may also post the final published version of the article immediately after publication.

Data Sharing and Data Availability

This journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation policy.

Data Protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley’s Data Protection Policy to learn more.

Funding

You should list all funding sources in the Acknowledgments section. You are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

ORCID

This journal encourages authors to provide ORCID. Please refer to Wiley’s resources on ORCID.

Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.

The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon submission.

Main Text File

The main text file should be in Word format.

The main document file should be prepared as follows.

Title Page

(i) A brief informative title of fewer than 90 characters

(ii) The full names of the authors;

(iii) The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;

(iv) Corresponding author(s) and email address(es).

Abstract

It is a separate paragraph to summarize problem statement, the objective, the method taken, the major findings, and the significance or implications of the results. The length is less than 250 words.

Impact Statement

The authors should present an Impact Statement before the main text, IN LAY LANGUAGE, highlighting the novelty and significance to a broad audience. The length is less than 100 words.

Keywords

A maximum of five keywords should be listed below the Impact Statement.

Introduction

This section is to introduce the background, knowledge gaps, questions, hypotheses, and the objectives of the research.

Results

This section is to provide a summary of the main findings of the research.

Discussion

This section should summarize the main results, describe the relations to other work and highlight the novelty and significance of the research. The results and discussion can be combined if it is better for presentation.

Materials and methods

This section is to introduce the materials, standard procedures, appropriate methods, statistical methods, etc. All novel materials and the procedures should be described in sufficient detail to allow their reproduction.

Acknowledgments

The authors should acknowledge persons who have contributed to the work presented but do not meet the criteria for authorship. In addition, the funding agencies and the grants directly supporting the work should be listed.

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/2770100x/homepage/author-guidelines


中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。